畜牧兽医学报 ›› 2020, Vol. 51 ›› Issue (1): 150-158.doi: 10.11843/j.issn.0366-6964.2020.01.017

• 基础兽医 • 上一篇    下一篇

Bta-miR-677靶向线粒体抗病毒信号蛋白影响Ⅰ型干扰素的生成

廖政1,2, 嵇辛勤1*, 李基棕2*, 肖芳1,2, 刘茂军2, 毛立2, 李文良2, 孙敏2   

  1. 1. 贵州大学动物科学学院, 贵阳 550025;
    2. 江苏省农业科学院兽医研究所, 农业部兽用生物制品工程技术重点实验室, 南京 210014
  • 收稿日期:2019-08-21 出版日期:2020-01-23 发布日期:2020-01-17
  • 通讯作者: 嵇辛勤,主要从事动物传染病防治和诊断技术研究,E-mail:jxq972@aliyun.com;李基棕,主要从事动物传染病防治和诊断技术研究,Tel:025-84391152,E-mail:lijizong22@sina.com
  • 作者简介:廖政(1993-),男,贵州黔东南苗族侗族自治州人,硕士,主要从事动物传染病防治和诊断技术研究,Tel:025-84391152,E-mail:320414112@qq.com
  • 基金资助:
    国家自然科学基金(31702272;31802196);江苏省自然科学基金(BK2017059)

Bta-miR-677 Up-regulated the Expression of Type Ⅰ Interferon by Targeting Mitochondria Antiviral Signaling Protein

LIAO Zheng1,2, JI Xinqin1*, LI Jizong2*, XIAO Fang1,2, LIU Maojun2, MAO Li2, LI Wenliang2, SUN Min2   

  1. 1. College of Animal Science of Guizhou University, Guiyang 550025, China;
    2. Key Laboratory of Veterinary Biological Engineering and Technology of the Ministry of Agriculture and Rural Affairs(MARA) of China, Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
  • Received:2019-08-21 Online:2020-01-23 Published:2020-01-17

摘要: 旨在探究bta-miR-677调控Ⅰ型干扰素(IFN)表达的分子机制。将bta-miR-677转染MDBK细胞,检测Ⅰ型IFN和干扰素刺激基因(ISGs)的转录水平;随后通过TargetScan预测bta-miR-677的靶基因,双荧光素酶报告基因系统、qRT-PCR和Western blot验证bta-miR-677的靶基因;利用siRNA敲减验证靶基因对Ⅰ型IFN转录的影响。结果显示,过表达bta-miR-677组IFN-α/β的转录水平高于对照组2~4倍(P<0.001),随后检测到6种ISGs(IFI6、OAS1Y、OAS1Z、RSAD2、MX1和MX2)转录量上调2~16倍(P<0.01或P<0.001);反之,抑制表达bta-miR-677组IFN-α/β转录量下调(P<0.01或P<0.05),同时IFI6、OAS1Y、OAS1Z、RSAD2、MX1和MX2转录量下调(P<0.05或P<0.01)。经TargetScan预测和双荧光素酶报告基因系统、qRT-PCR和Western blot检测显示,bta-miR-677可靶向结合线粒体抗病毒信号蛋白(MAVS)的3'-UTR,抑制MAVS蛋白的表达;MAVS基因敲减后发现,IFN-α、IFN-β和6种ISGs转录量上调。研究结果表明,bta-miR-677通过靶向MAVS上调IFN-α/β转录水平,进而提高ISGs的表达量,为基于bta-miR-677研制抗病毒药物提供了重要资料。

关键词: bta-miR-677, Ⅰ型干扰素, 干扰素刺激基因, 线粒体抗病毒信号蛋白

Abstract: This study was conducted to investigate the molecular mechanism of bta-miR-677 regulating the expression of type Ⅰ interferon (IFN). Bta-miR-677 was transfected into MDBK cells to detect the transcription level of type Ⅰ IFN and interferon stimulating genes (ISGs). Then we predicted the target gene of bta-miR-677 by TargetScan, and the target gene of bta-miR-677 was verified by dual-luciferase report gene system, qRT-PCR and Western blot assay. The effect of the target gene on IFN transcription was verified by siRNA knockdown. The results showed that the transcription of IFN-α/β in bta-miR-677 group were 2-4 times higher than that of the control group (P<0.001), moreover, the transcription of six ISGs(IFI6, OAS1Y, OAS1Z, RSAD2, MX1 and MX2) were up-regulated by 2-16 times (P<0.01 or P<0.001). By contrast, the transcription of IFN-α/β in bta-miR-677 inhibitor group were down-regulated (P<0.01 or P<0.05), then the transcription of IFI6, OAS1Y, OAS1Z, RSAD2, MX1 and MX2 were down-regulated (P<0.05 or P<0.01). Subsequently, we demonstrated that bta-miR-677 could target the 3'-UTR of MAVS (mitochondria antiviral signaling protein) and the expression of MAVS is inhibited. Meanwhile, silencing of MAVS up-regulated the expression of IFN-α/β and the six ISGs. The results showed that bta-miR-677 up-regulated the transcription level of IFN-α/β by targeting MAVS, and then increased the transcription of ISGs. This study reveals that bta-miR-677 up-regulated type Ⅰ IFN by targeting MAVS to increase the expression of ISGs, which provided important data for the development of antiviral drugs based on bta-miR-677.

Key words: bta-miR-677, typeⅠ interferon, interferon stimulating genes, mitochondria antiviral signaling protein

中图分类号: